Curon Stretta GERD Coverage Boost In 2005 Has Sales Force Salivating
This article was originally published in The Gray Sheet
Executive Summary
Curon Medical hopes to quintuple the reimbursement-eligible patient population for its minimally-invasive Stretta gastroesophogeal reflux disease (GERD) treatment by mid-2005